Summary
The serum of mice hyperimmune to L1210 leukemia was cytotoxic to L1210 cells and, to a much lesser extent, to P388 cells in the presence of complement. However, it did not suppress in vitro growth of L1210 cells, nor did it endow a recipient mouse with immunity to inoculated L1210 cells. This indicates that the serum did not play a significant role, if any, in immune protection of hyperimmune mice.
Spleen and peritoneal exudate cells of hyperimmune mice suppressed the in vitro growth of L1210 but not of P388 cells. This is consistent with the fact that hyperimmune mice did not survive the inoculation of P388 cells. The immunocytes failed to suppress the in vitro growth of L1210 cells when preincubated with anti-Thy-1.2 antisera and complement. This, together with the finding that cell populations not adherent to a plastic dish suppressed in vitro growth of L1210 cells, indicates that T cells of immune spleen and peritoneal exudate cell populations were the effectors that suppressed in vitro growth of L1210 cells. Hyperimmune mice lost their immune protection in vivo following the administration of anti-thymocyte antisera, but not with carrageenan or silica, which resulted in the lethal growth of the inoculated L1210 cells. This indicates that T cells were in vivo effectors in immune protection.
Hyperimmune spleen T cells endowed a recipient with immunity to L1210 leukemia when transferred in vivo. This confirmed the above results and suggests the applicability of immune cells in an adoptive immunotherapy approach.
Similar content being viewed by others
References
Berd, D., Prehn, R. T.: Peritoneal macrophage response to leukemia L1210 in syngeneic mice. J. Natl. Cancer Inst. 58, 1729 (1977)
Berenson, J. R., Einstein, A. B., Jr., Fefer, A.: Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells. J. Immunol. 115, 234 (1975)
Kataoka, T., Oh-hashi, F., Tsukagoshi, S., Sakurai, Y.: Induction of resistance to L1210 leukemia in Balb/c × DBA/2CrF1 mice with L1210 cells treated with glutaraldehyde and concanavalin A. Cancer Res. 37, 964 (1977)
Kataoka, T., Oh-hashi, F., Tsukagoshi, S., Sakurai, Y.: Enhanced induction of immune resistance by L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor. Cancer Res. 37, 4416 (1977)
Kataoka, T., Oh-hashi, F., Sakurai, Y.: Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. Cancer Res. 39, 2807 (1979)
Kataoka, T., Tsukagoshi, S., Sakurai, Y.: Transplantability of L1210 cell in Balb/c × DBA/2F1 mice associated with cell agglutinability by concanavalin A. Cancer Res. 35, 531 (1975)
Mihich, E.: Combined effects of chemotherapy and immunity against leukemia L1210 in DBA/2 mice. Cancer Res. 29, 848 (1969)
Mihich, E.: Modification of tumor regression by immunologic means. Cancer Res. 29, 2345 (1969)
Prager, M. D.: Experimental specific immunotherapy. In: Immunological aspects of cancer, p. 313. Lancaster, England: MTP Press 1978
Sethi, K. K., Brandis, H.: Neuraminidase-induced loss in the transplantability of murine leukemia L1210, induction of immunoprotection and the transfer of induced immunity to normal DBA/2 mice by serum and peritoneal cells. Br. J. Cancer 27, 106 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kataoka, T., Oh-hashi, F., Sakurai, Y. et al. Factors responsible for immune resistance to L1210 murine leukemia in hyperimmune mice. Cancer Immunol Immunother 7, 123–129 (1979). https://doi.org/10.1007/BF00205334
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205334